Nephrocare Health Services Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Limited regarding scheduled meetings with analysts and institutional investors. The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations.
Company officials will attend an investor conference hosted by IIFL Capital, characterized as a Non-Deal Roadshow. The meetings are scheduled for August 13 and 14, 2026, starting at 9:00 AM IST onwards in Mumbai. The nature of the meetings will include both one-on-one (1*1) and group meetings.
The company explicitly states that all discussions during these interactions will be based solely on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed. The disclosure notes that changes to the schedule may occur due to exigencies on the part of either the host (IIFL Capital) or the company.
This disclosure has been made available on the company's website at www.nephroplus.com. The communication is digitally signed by Kishore Kathri, Company Secretary & Head Legal (ICSI Membership No. F9895), on behalf of Nephrocare Health Services Limited.